Eton Pharmaceuticals to Participate at 2026 Wells Fargo Healthcare Conference

Rhea-AI Summary

Eton Pharmaceuticals (Nasdaq: ETON) announced that members of its executive leadership team will participate in 1x1 investor meetings at the 2026 Wells Fargo Healthcare Conference in Boston, MA. The meetings are scheduled for September 9, 2026, during the conference running from September 8–10, 2026. Institutional investors interested in scheduling a 1x1 meeting are instructed to contact their Wells Fargo institutional sales representative.

Market Context

The prior second-quarter earnings release was followed by a 44.31% 24-hour move, whereas this notice...

Analysis

The prior second-quarter earnings release was followed by a 44.31% 24-hour move, whereas this notice contains no results or guidance. Its informational value rests on subsequent company disclosures; insider Net Selling is a recorded risk context.

Key Figures

Meeting format: 1x1 meetings Meeting date: September 9, 2026 Conference dates: September 8-10, 2026

3 metrics

Meeting format 1x1 meetings 2026 Wells Fargo Healthcare Conference

Meeting date September 9, 2026 2026 Wells Fargo Healthcare Conference

Conference dates September 8-10, 2026 Boston, MA

Historical Context

5 past events · Latest: Aug 13 (Positive)

Pattern 5 events

Date	Event	Sentiment	24h Move	Catalyst
Aug 13	Second-quarter earnings	Positive	+44.3%	Record quarterly revenue, raised guidance, and stronger profitability drove the announcement.
Aug 05	ASN-001 licensing	Positive	+0.3%	U.S. rights acquisition expanded the infantile hemangioma product portfolio.
Aug 03	Earnings date notice	Neutral	-2.8%	The company scheduled its second-quarter financial results release and conference call.
Jul 29	KHINDIVI label submission	Positive	+3.1%	A prior approval supplement sought a younger-pediatric indication expansion.
May 19	IMPAVIDO rights agreement	Positive	+4.7%	Exclusive U.S. commercialization rights broadened the rare-disease portfolio.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

The four substantive positive announcements in the supplied history had positive 24-hour reactions, while the earnings-date notice had a negative reaction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

DEER PARK, Ill., Aug. 27, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that members of the Company’s executive leadership team will host 1x1 meetings on September 9, 2026 at the 2026 Wells Fargo Healthcare Conference being held September 8-10, 2026 in Boston, MA.

To schedule a 1x1 meeting with the Company, please contact your Wells Fargo institutional sales representative.

About Eton Pharmaceuticals

Eton is an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases. The Company currently has eleven commercial rare disease products: KHINDIVI ^®, INCRELEX^®, ALKINDI SPRINKLE^®, DESMODA™, GALZIN^®, HEMANGEOL^®, PKU GOLIKE^®, IMPAVIDO^® (September 2026 launch), Carglumic Acid, Betaine Anhydrous, and Nitisinone. The Company has five additional product candidates in late-stage development: ASN-001, AMGLIDIA^®, ET-700, ET-800, and ZENEO^® hydrocortisone autoinjector. For more information, please visit our website at www.etonpharma.com.

Investor Relations:
Lisa M. Wilson, In-Site Communications, Inc.
T: 212-452-2793
E: lwilson@insitecony.com

Source: Eton Pharmaceuticals.

FAQ

When will Eton Pharmaceuticals (NASDAQ: ETON) attend the 2026 Wells Fargo Healthcare Conference?

Eton Pharmaceuticals will host 1x1 meetings on September 9, 2026 during the 2026 Wells Fargo Healthcare Conference. According to Eton, the conference itself runs from September 8–10, 2026 in Boston, Massachusetts.

What is Eton Pharmaceuticals planning to do at the 2026 Wells Fargo Healthcare Conference?

Eton Pharmaceuticals plans to conduct 1x1 meetings with investors at the 2026 Wells Fargo Healthcare Conference. According to Eton, members of the company’s executive leadership team will host these meetings on September 9, 2026, in Boston, MA.

How can investors schedule a 1x1 meeting with Eton Pharmaceuticals at the 2026 Wells Fargo Healthcare Conference?

Investors can schedule a 1x1 meeting with Eton Pharmaceuticals by contacting their Wells Fargo institutional sales representative. According to Eton, Wells Fargo representatives are coordinating the scheduling of these meetings for the September 9, 2026 conference day.

Where is the 2026 Wells Fargo Healthcare Conference with Eton Pharmaceuticals being held?

The 2026 Wells Fargo Healthcare Conference featuring Eton Pharmaceuticals’ 1x1 meetings is being held in Boston, Massachusetts. According to Eton, its executive leadership team will meet investors there on September 9, 2026, during the multi-day event.

Will Eton Pharmaceuticals present publicly or only hold 1x1 meetings at the 2026 Wells Fargo Healthcare Conference?

Eton Pharmaceuticals has announced 1x1 investor meetings at the conference; no public presentation was mentioned. According to Eton, the focus is on scheduled meetings with investors arranged through Wells Fargo institutional sales representatives.